Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission.
View / Open Files
Authors
Snell, Luke B
Fisher, Chloe L
Taj, Usman
Stirrup, Oliver
Merrick, Blair
Alcolea-Medina, Adela
Charalampous, Themoula
Signell, Adrian W
Wilson, Harry D
Betancor, Gilberto
Kia Ik, Mark Tan
Cunningham, Emma
Cliff, Penelope R
Pickering, Suzanne
Galao, Rui Pedro
Batra, Rahul
Neil, Stuart JD
Malim, Michael H
Doores, Katie J
Douthwaite, Sam T
Nebbia, Gaia
COVID-19 Genomics UK (COG-UK) consortium
Edgeworth, Jonathan D
Awan, Ali R
Publication Date
2022-01Journal Title
Clin Microbiol Infect
ISSN
1198-743X
Publisher
Elsevier BV
Language
eng
Type
Article
This Version
AM
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Snell, L. B., Fisher, C. L., Taj, U., Stirrup, O., Merrick, B., Alcolea-Medina, A., Charalampous, T., et al. (2022). Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission.. Clin Microbiol Infect https://doi.org/10.1016/j.cmi.2021.07.040
Abstract
OBJECTIVES: To analyse nosocomial transmission in the early stages of the coronavirus 2019 (COVID-19) pandemic at a large multisite healthcare institution. Nosocomial incidence is linked with infection control interventions. METHODS: Viral genome sequence and epidemiological data were analysed for 574 consecutive patients, including 86 nosocomial cases, with a positive PCR test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first 19 days of the pandemic. RESULTS: Forty-four putative transmission clusters were found through epidemiological analysis; these included 234 cases and all 86 nosocomial cases. SARS-CoV-2 genome sequences were obtained from 168/234 (72%) of these cases in epidemiological clusters, including 77/86 nosocomial cases (90%). Only 75/168 (45%) of epidemiologically linked, sequenced cases were not refuted by applying genomic data, creating 14 final clusters accounting for 59/77 sequenced nosocomial cases (77%). Viral haplotypes from these clusters were enriched 1-14x (median 4x) compared to the community. Three factors implicated unidentified cases in transmission: (a) community-onset or indeterminate cases were absent in 7/14 clusters (50%), (b) four clusters (29%) had additional evidence of cryptic transmission, and (c) in three clusters (21%) diagnosis of the earliest case was delayed, which may have facilitated transmission. Nosocomial cases decreased to low levels (0-2 per day) despite continuing high numbers of admissions of community-onset SARS-CoV-2 cases (40-50 per day) and before the impact of introducing universal face masks and banning hospital visitors. CONCLUSION: Genomics was necessary to accurately resolve transmission clusters. Our data support unidentified cases-such as healthcare workers or asymptomatic patients-as important vectors of transmission. Evidence is needed to ascertain whether routine screening increases case ascertainment and limits nosocomial transmission.
Keywords
COVID-19 Genomics UK (COG-UK) consortium, Funding Acquisition, Leadership, Supervision, Metadata Curation, Project Administration, Samples, Logistics, Sequencing, Analysis, and Software and Analysis Tools, Leadership, Supervision, Sequencing, Analysis, Funding Acquisition, Metadata Curation, Project Administration, Samples, Logistics, and Visualisation, Leadership, Supervision, Project Administration, Visualisation, Samples, Logistics, Metadata Curation and Software and Analysis Tools, Leadership, Supervision, Metadata Curation, Project Administration, Samples, Logistics Sequencing and Analysis, Project Administration, Metadata Curation, Samples, Logistics, Sequencing, Analysis, and Software and Analysis Tools, Leadership, Supervision, Samples Logistics, Project Administration, Funding Acquisition Sequencing and Analysis, Leadership and Supervision, Sequencing, Analysis, Funding Acquisition, Visualisation and Software and Analysis Tools, Leadership and Supervision, Funding Acquisition, Sequencing, Analysis, Metadata Curation, Samples and Logistics, Leadership Supervision, Sequencing Analysis, Samples, Logistics, and Metadata Curation, Leadership, Supervision, Sequencing, Analysis, Samples, Logistics, and Project Administration, Project Administration, Metadata Curation, Samples, Logistics, Sequencing and Analysis, Project Administration Sequencing and Analysis, Sequencing, Analysis, Project Administration, Metadata Curation and Software and Analysis Tools, Leadership, Supervision, Funding Acquisition, Samples, Logistics, and Metadata Curation, Leadership, Supervision, Metadata Curation, Samples, Logistics, Sequencing and Analysis, Metadata Curation, Sequencing, Analysis, Leadership, Supervision and Software and Analysis Tools, Leadership, Supervision, Visualisation, Sequencing, Analysis and Software and Analysis Tools, Sequencing, Analysis, Samples, Logistics, Metadata Curation, and Visualisation, Metadata Curation, Sequencing, Analysis, Visualisation, Software and Analysis Tools, Sequencing, Analysis, Visualisation, Metadata Curation, and Software and Analysis Tools, Funding Acquisition, Leadership, Supervision and Project Administration, Project Administration, Samples, Logistics, Leadership and Supervision, Sequencing, Analysis, Project Administration and Metadata Curation, Samples, Logistics, Metadata Curation and Project Administration, Leadership, Supervision, Funding Acquisition and Metadata Curation, Leadership, Supervision, Funding Acquisition, Sequencing and Analysis, Leadership, Supervision, Metadata Curation, Sequencing and Analysis, Leadership, Supervision, Samples, Logistics and Metadata Curation, Sequencing, Analysis, Leadership, Supervision, Samples and Logistics, Sequencing, Analysis, Leadership and Supervision and Software and Analysis Tools, Samples, Logistics, Sequencing, Analysis and Metadata Curation, Sequencing, Analysis, Metadata Curation, and Software and Analysis Tools, Sequencing, Analysis, Metadata Curation and Visualisation, Visualisation, Sequencing, Analysis and Software and Analysis Tools, Project Administration, Leadership and Supervision, Project Administration and Funding Acquisition, Sequencing, Analysis and Project Administration, Samples, Logistics, and Project Administration, Project Administration, Software and Analysis Tools, Project Administration and Visualisation, Leadership, Supervision, and Funding Acquisition, Leadership, Supervision and Metadata Curation, Leadership, Supervision, Sequencing and Analysis, Samples, Logistics, Leadership and Supervision, Leadership, Supervision and Visualisation, Sequencing, Analysis and Metadata Curation, Samples, Logistics and Metadata Curation, Sequencing, Analysis, Samples and Logistics, Sequencing, Analysis and Software and Analysis Tools, Samples, Logistics and Software and Analysis Tools, Visualisation and Software and Analysis Tools, Project Administration, Leadership and Supervision, Metadata Curation, Sequencing and Analysis, Samples and Logistics, Software and Analysis Tools, Visualisation
Sponsorship
Thiswork was supported by the King's Together Multi and Interdisci-plinary Research Scheme (Wellcome Trust Revenue RetentionAward) and the National Institute for Health Research (NIHR)Biomedical Research Centre programme of Infection and Immunity(RJ112/N027) based at Guy's and St Thomas' National Health Ser-vice (NHS) Foundation Trust and King's College London. COG-UK issupported by funding from the Medical Research Council (MRC)part of UK Research&Innovation (UKRI), the National Institute ofHealth Research (NIHR) and Genome Research Limited, operatingas the Wellcome Sanger Institute. This work was also supported bythe Guy's and St Thomas' Charity.
Funder references
MRC (MC_PC_19027)
Medical Research Council (MC_PC_19027)
Embargo Lift Date
2022-08-13
Identifiers
External DOI: https://doi.org/10.1016/j.cmi.2021.07.040
This record's URL: https://www.repository.cam.ac.uk/handle/1810/331210
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc-nd/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.